This blog will explore the importance, features, benefits, challenges, and future trends associated with pharmacy delivery software. Whether you’re a pharmacy owner, healthcare provider ...

Amicus Therapeutics (FOLD) reported Q3 results that caught investors’ attention, posting GAAP profitability along with solid revenue gains from its rare disease therapies. Global expansion and ...

Courtly Observations is a recurring series by Erwin Chemerinsky that focuses on what the Supreme Court’s decisions will mean for the law, for lawyers and lower courts, and for people’s lives. Please ...

The Supreme Court is, apparently, reading its amicus briefs — and one of them may provide an offramp from immediately having to decide whether President Trump has the power to deploy the National ...

Amicus Therapeutics remains a Buy, supported by strong momentum in Galafold and Pombiliti/Opfolda, both with blockbuster potential. FOLD's Galafold leads in Fabry disease as the first oral precision ...

PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, ...

For years, we've all driven by the "big green round thing" — as our kids like to call it — in Downtown Tallahassee and wondered, "Is anything ever gonna go in the Old City Waterworks building? Seems ...

A group of 16 Republican-led states asked to file an amicus brief on Sunday in support of the Trump administration against Harvard’s lawsuit over its effort to strip billions of dollars of its federal ...

Amicus Therapeutics is a commercial-stage biotech with a focused pipeline in Fabry, Pompe, and rare kidney diseases. Galafold, its lead therapy, is the only approved oral treatment for Fabry disease ...

A federal judiciary committee gave final approval to new disclosure requirements for parties filing amicus briefs, teeing up the changes to be adopted. The Judicial Conference’s Committee on Rules of ...

More than 12,000 Harvard alumni asked a federal judge Monday to accept an amicus brief urging the court to shield their alma mater from what they described as an “existential threat” posed by the ...

Brown and 23 fellow research institutions filed an amicus brief in support of Harvard University’s lawsuit challenging a funding freeze imposed by the federal government. PROVIDENCE, R.I. [Brown ...